Immune Control of Group B Streptococcal Placental

B 族链球菌胎盘的免疫控制

基本信息

  • 批准号:
    10463639
  • 负责人:
  • 金额:
    $ 89.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Intra-amniotic infection and inflammation remain a significant cause of preterm birth, stillbirth and neonatal morbidity and mortality. The objective of this proposal is to define early maternal and placental immune responses that are critical for resolution of bacterial infections at the maternal-fetal interface. Elucidation of immune events occurring at the maternal-fetal interface in human pregnancy is complicated by the inaccessibility of maternal and fetal compartments, which also imposes limitations on our understanding of the nature of the invading organism and cell types directing bacterial clearance. We have overcome these challenges by using a unique chronically catheterized pregnant nonhuman primate (NHP) model that closely emulates human pregnancy. In this proposal, we will elucidate early immune mechanisms that result in bacterial clearance and define the key immune cell-types and host defense networks that protect the fetus from invasive bacterial infections. We will use the established NHP model of GBS infection to study bacterial clearance at the maternal-fetal interface using innovative methods including: 1) multidimensional flow cytometry to quantitate immune cell populations at the maternal-fetal interface, 2) single cell RNA-Seq to generate a transcriptional map of cell types and regulatory gene networks, 3) reverse phase protein array to analyze signalling cascades and host translational networks and 4) sophisticated computational modelling to link clinical metadata (e.g. bacterial burden, peak uterine activity) with single cell RNA-Seq and protein array data. The proposed aims will thus establish the temporal and spatial nature of immune responses and host transcriptional and translational networks essential for bacterial clearance at the maternal-fetal interface during pregnancy.
项目摘要/摘要 羊膜内感染和炎症仍然是早产、死产和新生儿窒息的重要原因。 发病率和死亡率。这项建议的目的是确定早期母体和胎盘免疫 这些反应对于解决母胎界面处的细菌感染至关重要。阐明 在人类妊娠中发生在母胎界面的免疫事件是复杂的 母亲和胎儿室的不可接近性,这也限制了我们对 入侵生物体的性质和指导细菌清除的细胞类型。我们已经克服了这些 通过使用独特的长期插管妊娠非人灵长类动物(NHP)模型, 模仿人类怀孕在这个提议中,我们将阐明导致 细菌清除和定义关键的免疫细胞类型和宿主防御网络,保护胎儿免受 侵入性细菌感染。我们将利用已建立的GBS感染NHP模型, 使用创新方法清除母胎界面,包括:1)多维流动 流式细胞术以定量母胎界面处的免疫细胞群体,2)单细胞RNA-Seq以 生成细胞类型和调控基因网络的转录图谱,3)反相蛋白阵列, 分析信号级联和宿主翻译网络,以及4)复杂的计算建模, 将临床元数据(例如细菌负荷、峰值子宫活动)与单细胞RNA-Seq和蛋白质阵列相关联 数据因此,所提出的目标将确定免疫反应和宿主的时间和空间性质。 转录和翻译网络对母体-胎儿界面的细菌清除至关重要, 怀孕

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KRISTINA M. ADAMS WALDORF其他文献

KRISTINA M. ADAMS WALDORF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KRISTINA M. ADAMS WALDORF', 18)}}的其他基金

Influenza pathogenesis in pregnancy
妊娠期流感发病机制
  • 批准号:
    10615124
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
JAK-STAT Control of Zika Virus-Induced Fetal Injury
JAK-STAT 控制寨卡病毒引起的胎儿损伤
  • 批准号:
    10321508
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
Influenza pathogenesis in pregnancy
妊娠期流感发病机制
  • 批准号:
    10428661
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
Influenza pathogenesis in pregnancy
妊娠期流感发病机制
  • 批准号:
    10312331
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth
靶向抑制白细胞介素 1 β (IL-1 beta) 预防早产
  • 批准号:
    10617680
  • 财政年份:
    2020
  • 资助金额:
    $ 89.14万
  • 项目类别:
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth
靶向抑制白细胞介素 1 β (IL-1 beta) 预防早产
  • 批准号:
    10162632
  • 财政年份:
    2020
  • 资助金额:
    $ 89.14万
  • 项目类别:
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth
靶向抑制白细胞介素 1 β (IL-1 beta) 预防早产
  • 批准号:
    10400199
  • 财政年份:
    2020
  • 资助金额:
    $ 89.14万
  • 项目类别:
JAK-STAT Control of Zika Virus-Induced Fetal Injury
JAK-STAT 控制寨卡病毒引起的胎儿损伤
  • 批准号:
    10189500
  • 财政年份:
    2019
  • 资助金额:
    $ 89.14万
  • 项目类别:
JAK-STAT Control of Zika Virus-Induced Fetal Injury
JAK-STAT 控制寨卡病毒引起的胎儿损伤
  • 批准号:
    10668233
  • 财政年份:
    2019
  • 资助金额:
    $ 89.14万
  • 项目类别:
JAK-STAT Control of Zika Virus-Induced Fetal Injury
JAK-STAT 控制寨卡病毒引起的胎儿损伤
  • 批准号:
    10441333
  • 财政年份:
    2019
  • 资助金额:
    $ 89.14万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 89.14万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 89.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了